Zobrazeno 1 - 10
of 345
pro vyhledávání: '"J.J. López-Ibor"'
Autor:
J.J. López-Ibor
Publikováno v:
Educación Médica, Vol 11, Pp 53-61 (2008)
Externí odkaz:
https://doaj.org/article/d289c0bc43e04941bca6b4f60f27e635
Autor:
J.J. López-Ibor
Publikováno v:
Educación Médica, Vol 11, Iss suppl 1, Pp 53-61
Externí odkaz:
https://doaj.org/article/31b09604b697468fabe74680d849d2aa
Publikováno v:
Dementia and Geriatric Cognitive Disorders. 18:50-54
A study was performed on patients with Alzheimer’s disease (AD) in order to evaluate the efficacy of a combined treatment (donepezil plus cognitive training) in both cognitive processes and affective states. Eighty-six subjects, 25 men and 61 women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a02a71f0f3757ab3010735fe1fad71b4
https://doi.org/10.1159/000077735
https://doi.org/10.1159/000077735
Autor:
A. Jiménez Vicioso, J.L. Carreras Delgado, J. Coullaut Jáuregui, R Montz Andrée, J.J. López-Ibor Aliño
Publikováno v:
Revista Española de Medicina Nuclear. 21:370-386
A principios del siglo XX algunos autores ya pensaban que la «demencia precoz» tenia una base organica, sin embargo por entonces no se disponia de los metodos de imagen necesarios para medir in vivo las posibles alteraciones cerebrales. Mas tarde,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9921cd49867d08654f793ce111dbff35
https://doi.org/10.1016/s0212-6982(02)72110-1
https://doi.org/10.1016/s0212-6982(02)72110-1
Autor:
J.J. López-Ibor, J. Saiz, J. Cottraux, I. Note, R. Viñas, M. Bourgeois, M. Hernández, J.C. Gómez-Pérez
Publikováno v:
European Neuropsychopharmacology. 6:111-118
There is evidence of the clinical efficacy and safety of clomipramine and the newer selective serotonin reuptake inhibitors (SSRIs) for the treatment of obsessive-compulsive disorder (OCD). In the present study, we have compared the efficacy and safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7e91e214b958312222f163664f8a7b6
https://doi.org/10.1016/0924-977x(95)00071-v
https://doi.org/10.1016/0924-977x(95)00071-v
Autor:
J.J. López-Ibor
Publikováno v:
Educación Médica v.11 suppl.1 2008
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Educación Médica, Vol 11, Iss suppl 1, Pp 53-61
Educación Médica, Volume: 11 Supplement 1, Pages: 53-61, Published: DEC 2008
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Educación Médica, Vol 11, Iss suppl 1, Pp 53-61
Educación Médica, Volume: 11 Supplement 1, Pages: 53-61, Published: DEC 2008
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e0b201231b201d382ecd3f4fe60c08
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1575-18132008000500011
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1575-18132008000500011
Autor:
J.J. López-Ibor
Publikováno v:
European Neuropsychopharmacology. 2:210-212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bc662332283c4500776b8ca19237cac
https://doi.org/10.1016/0924-977x(92)90068-j
https://doi.org/10.1016/0924-977x(92)90068-j
Publikováno v:
European Neuropsychopharmacology. 2:87-89
A case of schiophrenia with neuroleptic malignant syndrome (NMS) presented difficulties in differential diagnosis. However, the presence of severe galactorrhea contributed decisively to relate the clinical picture with the administration of neurolept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1107e0d54c11e6c6e6bc404e5f193e77
https://doi.org/10.1016/0924-977x(92)90040-f
https://doi.org/10.1016/0924-977x(92)90040-f
Publikováno v:
Revista de la Fundación Educación Médica. 16:77
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfd7f0e7468e812f65095b6ec7dab6e3
https://doi.org/10.33588/fem.162.683
https://doi.org/10.33588/fem.162.683
Publikováno v:
European Psychiatry. 26:881-881
IntroductionPegylated-interferon (pegIFN) plus ribavirin (RBV) is for the moment the licensed therapy for chronic hepatitis C. Neuropsychiatric symptoms are frequent side effects due to the treatment with pegIFN, registered in 30 to 80% of instances,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38779726c8ce0ff61bea6994914ab98a
https://doi.org/10.1016/s0924-9338(11)72586-x
https://doi.org/10.1016/s0924-9338(11)72586-x